Latest Breaking News On - குன்றின் எம்மோன்ஸ் - Page 6 : comparemela.com

IIoT-OXYS Inc.: IIOT-OXYS, Inc. Enters into NDA with New England-Based Biotech Start-Up CAMBRIDGE, MA / ACCESSWIRE / February 24, 2021 / IIOT-OXYS, Inc. (OTC PINK:ITOX) announced the execution of a Non-Disclosure Agreement (NDA) with a New England based biotechnology start-up. Cliff Emmons, CEO of IIOT-OXYS, Inc., stated, This customer manufactures novel medical device implants, which are currently undergoing clinical trials. The company has been operating for over a decade and received significant funding within the past year to fund operations, clinical trials, and regulatory approval of their devices. Our customer engagement process consists of several steps, the first being the execution of an NDA, which then allows us to quickly define a problem statement of interest to the client, which then leads to a definition of scope of work for the first contract. We are very pleased to be working with this innovative company that can leverage our technology to ensure the quality and p

United kingdomKostenloser wertpapierhandelAingura iioCliffordl emmonsCliff emmonsExchange commissionIiot oxys incStructural healthNon disclosure agreementNew englandEdge computingMinimally invasive load monitoringஒன்றுபட்டது கிஂக்டம்குன்றின் எம்மோன்ஸ்பரிமாற்றம் தரகுகட்டமைப்பு ஆரோக்கியம்